Figure 5From: In vitro enhancement of dendritic cell-mediated anti-glioma immune response by graphene oxidePhenotype and cellular viability studies of the DCs after stimulation. (A) Flow cytometry evaluation of CD86, CD83, and HLA-DR expression on DCs treated with GO, Ag, or GO-Ag. (B) Viability of DCs after being treated with 0.1 μg/mL of GO for 1, 4, or 24 h (mean ± std, n = 6).Back to article page